- From: Sean Martin <sjmm@us.ibm.com>
- Date: Thu, 20 Jul 2006 06:57:05 -0400
- To: public-semweb-lifesci@w3.org
- Message-ID: <OFBA7051BD.60746B97-ON852571B1.003B9892-852571B1.003C2851@us.ibm.com>
hi Susie, Is there any chance that we can have a section that details the pro's and con's of URL's as URIs in a Life Sciences setting. It is my understanding that the LSID URN was created in response to certain short comings of URLs as names - but may well not have over come them and so the various concerns may not be obvious with just the one table suggested. Kindest regards, Sean -- Sean Martin IBM Corp. SUSIE.STEPHENS@ORACLE.COM Sent by: public-semweb-lifesci-request@w3.org 07/19/2006 06:33 PM To "'public-semweb-lifesci'" <public-semweb-lifesci@w3.org> cc Subject BioRDF: URI Best Practices I've added a section on URIs to the BioRDF Wiki ( http://esw.w3.org/topic/HCLSIG_BioRDF_Subgroup/Tasks/URI_Best_Practices). Please could you add your thoughts to the Wiki prior to the BioRDF call on July 31 that will discuss the pros and cons of using LSIDs. Thanks, Susie
Received on Thursday, 20 July 2006 10:57:38 UTC